BridgeBio Pharma (BBIO) Q1 2026 Earnings

24FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1
-0.9
-0.81
-0.71

Details

Expected EPS
-0.713428
Actual EPS
-1
Surprise EPS
-0.29
Surprise Percent
+40.17%

Description

BridgeBio Pharma (BBIO) has reported earnings of -1 per share for Q1 2026.

0 Comments

Share your thoughts